MedPath

丽珠集团新北江制药股份有限公司

Ownership
-
Established
1993-03-28
Employees
-
Market Cap
-
Website
https://www.livzon-nnr.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Acarbose

Product Name
阿卡波糖
Approval Number
国药准字H20113449
Approval Date
Aug 26, 2021
NMPA

Tobramycin

Product Name
妥布霉素
Approval Number
国药准字H44020803
Approval Date
Jul 2, 2020
NMPA

Pravastatin Sodium

Product Name
普伐他汀钠
Approval Number
国药准字H20080672
Approval Date
Jul 24, 2018
NMPA

Lovastatin

Product Name
洛伐他汀
Approval Number
国药准字H20065609
Approval Date
Mar 22, 2018
NMPA

Mycophenolate Mofetil

Product Name
吗替麦考酚酯
Approval Number
国药准字H20073809
Approval Date
Nov 23, 2017
NMPA

Ribavirin Injection

Product Name
利巴韦林注射液
Approval Number
国药准字H20067205
Approval Date
Jul 21, 2006
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H20067204
Approval Date
Jul 21, 2006
NMPA

Cefaclor Capsules

Product Name
头孢克洛胶囊
Approval Number
国药准字H20045343
Approval Date
Oct 22, 2004
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H20045349
Approval Date
Oct 22, 2004
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H20045347
Approval Date
Oct 20, 2004
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.